Our No. 2 story,
on gene editing in viable human embryos, reminds us of the many intricacies of human biology.
No matter your
position on gene editing, you owe it to yourself to get educated about the changes coming to medicine in the next few years.
Meanwhile in the U.S., the National Institutes of Heath restated its
ban on gene editing of human embryos.
Soon after the results were published — by the open - access journal Protein & Cell — the National Institutes of Health reaffirmed its ban
on gene editing of human embryos.
In the absence of any international body that would be an obvious fit to enforce international
regulations on gene editing there are historical precedents — like stem cell research — for providing guidance and then leaving the specifics up to regional authorities.
Prof Robin Lovell Badge, Crick Institute, on the science: «The experiments reported by Junjiu Huang and colleagues (Liang et al) in the journal Protein
Cell on gene editing in abnormally fertilised human embryos are, I expect, the first of several that we will see this year.
When a committee of the National Academies issued a new
report on gene editing, the MIT Technology Review's headline said: «U.S. Panel Endorses Designer Babies to Avoid Serious Disease.»
A new
twist on gene editing makes the CRISPR / Cas9 molecular scissors act as a highlighter for the genetic instruction book.
The international
summit on gene editing, sponsored by Britain's Royal Society, the Chinese Academy of Sciences, and the US National Academies, has grappled with such thorny questions during three days of sometimes - heated discussion on editing the human genome that comes to a close today.
The Oct. 11 - 13 conference, based in Hanover, Germany, assembled a global group of bioethics and government experts to address security
questions on gene editing as they relate to human health, agriculture and the potential to genetically alter species.
Regulatory debate Huang's team's April report spawned a flurry of scientific and policy meetings and statements as governments and policy experts wrestled with how or whether to draw the
line on gene editing in human embryos.
The plea was made by those
working on gene editing with adult cells who are concerned that embryo editing could have unpredictable effects on future generations and stimulate a public outcry.
In the coming months, four US clinics will recruit people with HIV to a trial of a therapy
based on gene editing.
So serious that a historical summit is being held, and its co-developer, Dr. Jennifer Douda, is asking everyone to put the
kibosh on gene editing until they've had a chance to have a good, long chat about the ethics surrounding it.
«The experiments reported by Junjiu Huang and colleagues (Liang et al) in the journal Protein
Cell on gene editing in abnormally fertilised human embryos are, I expect, the first of several that we will see this year.